This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
SEMAGLUTIDE
$
149 AUD
Product Info
Semaglutide is a synthetic peptide research compound that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. It is commonly used in laboratory research to study metabolic regulation, glucose homeostasis, and endocrine signalling pathways. Semaglutide is of interest in controlled experimental settings exploring appetite regulation, insulin signalling, and peptide–receptor interactions. This compound is supplied strictly for research purposes only and is not intended for human or veterinary use.
Buy 3 and save 15%
Buy 5 and save 20%
Categories
Bacteriostatic Water
AOD
Cagrilintide
Cagrilintide + Semaglutide
Retatrutide
Semaglutide
Tirzepatide
SLU PP 332
MOTS C
BPC 157
bpc-157-tb-500
Description
Overview
Biochemical Characteristics
Research Applications
Pathway / Mechanistic Context
Form & Analytical Testing
RUO Disclaimer
Overview
Biochemical Characteristics
Research Applications
Pathway / Mechanistic Context
Form & Analytical Testing
RUO Disclaimer
Overview
Semaglutide is a synthetic GLP-1 receptor agonist—a 31-amino acid peptide analog of glucagon-like peptide-1 (GLP-1) with enhanced receptor selectivity and extended half-life. The peptide is designed to mimic natural GLP-1 signaling and promote glucose homeostasis and metabolic health. Semaglutide is extensively studied for its potential in supporting glucose control, body weight management, and metabolic function. Research indicates the peptide enhances insulin secretion, reduces glucagon release, slows gastric emptying, and promotes satiety through GLP-1 receptor activation in pancreatic, gastrointestinal, and central nervous system tissues. Semaglutide represents a valuable research tool for investigating GLP-1 physiology, glucose metabolism, obesity mechanisms, and therapeutic approaches to type 2 diabetes and metabolic dysfunction.
Overview
Semaglutide is a synthetic GLP-1 receptor agonist—a 31-amino acid peptide analog of glucagon-like peptide-1 (GLP-1) with enhanced receptor selectivity and extended half-life. The peptide is designed to mimic natural GLP-1 signaling and promote glucose homeostasis and metabolic health. Semaglutide is extensively studied for its potential in supporting glucose control, body weight management, and metabolic function. Research indicates the peptide enhances insulin secretion, reduces glucagon release, slows gastric emptying, and promotes satiety through GLP-1 receptor activation in pancreatic, gastrointestinal, and central nervous system tissues. Semaglutide represents a valuable research tool for investigating GLP-1 physiology, glucose metabolism, obesity mechanisms, and therapeutic approaches to type 2 diabetes and metabolic dysfunction.
Biochemical Characteristics
Semaglutide is a 31-amino acid peptide with molecular weight of approximately 4,113 Da. The peptide is a GLP-1 analog modified with fatty acid acylation (palmitic acid via glutamic acid spacer) enabling albumin binding and extended serum half-life. The peptide is water-soluble and demonstrates excellent stability across physiological pH ranges (6.5–8.0). The albumin-binding modification reduces renal clearance and provides sustained biological activity for extended periods. Semaglutide resists enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) and other peptidases, maintaining active drug concentrations. Cellular uptake occurs through GLP-1 receptor binding and internalization. The peptide localizes to pancreatic islet cells, gastrointestinal epithelium, and central nervous system regions involved in appetite regulation.
Biochemical Characteristics
Semaglutide is a 31-amino acid peptide with molecular weight of approximately 4,113 Da. The peptide is a GLP-1 analog modified with fatty acid acylation (palmitic acid via glutamic acid spacer) enabling albumin binding and extended serum half-life. The peptide is water-soluble and demonstrates excellent stability across physiological pH ranges (6.5–8.0). The albumin-binding modification reduces renal clearance and provides sustained biological activity for extended periods. Semaglutide resists enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) and other peptidases, maintaining active drug concentrations. Cellular uptake occurs through GLP-1 receptor binding and internalization. The peptide localizes to pancreatic islet cells, gastrointestinal epithelium, and central nervous system regions involved in appetite regulation.
Research Applications
Glucose Homeostasis Investigation of semaglutide-induced enhancement of insulin secretion and glucose control in metabolic models. Type 2 Diabetes Models Assessment of glycemic control and improvements in HbA1c levels in diabetes research models. Weight Management Study of body weight reduction through appetite suppression and enhanced satiety signaling. Metabolic Health Investigation of improvements in lipid profiles, metabolic rate, and energy expenditure. Insulin Sensitivity Assessment of enhancement of peripheral tissue insulin sensitivity and beta cell function preservation. Cardiovascular Outcomes Study of protective effects on cardiovascular function and atherosclerosis prevention in metabolic disease models. Gastrointestinal Function Investigation of effects on gastric motility, nutrient absorption, and gut barrier function.
Research Applications
Glucose Homeostasis Investigation of semaglutide-induced enhancement of insulin secretion and glucose control in metabolic models. Type 2 Diabetes Models Assessment of glycemic control and improvements in HbA1c levels in diabetes research models. Weight Management Study of body weight reduction through appetite suppression and enhanced satiety signaling. Metabolic Health Investigation of improvements in lipid profiles, metabolic rate, and energy expenditure. Insulin Sensitivity Assessment of enhancement of peripheral tissue insulin sensitivity and beta cell function preservation. Cardiovascular Outcomes Study of protective effects on cardiovascular function and atherosclerosis prevention in metabolic disease models. Gastrointestinal Function Investigation of effects on gastric motility, nutrient absorption, and gut barrier function.
Pathway / Mechanistic Context
GLP-1 Receptor Activation Semaglutide binds and activates glucagon-like peptide-1 (GLP-1) receptors on pancreatic beta cells, intestinal L-cells, and brain neurons, triggering cAMP-dependent signaling cascades. Insulin Secretion Enhancement GLP-1 receptor activation on beta cells promotes insulin synthesis and glucose-dependent secretion, enhancing insulin availability and glucose uptake in peripheral tissues. Glucagon Suppression Semaglutide suppresses glucagon release from alpha cells in response to GLP-1 receptor signaling, reducing hepatic glucose production and supporting glycemic control. Gastric Motility Slowing The peptide slows gastric emptying through GLP-1 receptor activation on vagal afferent neurons, reducing meal-stimulated glucose excursions and promoting satiety. Central Appetite Suppression Semaglutide crosses blood-brain barrier and activates GLP-1 receptors in hypothalamic appetite centers, reducing hunger signals and enhancing satiety. Beta Cell Preservation GLP-1 signaling promotes beta cell proliferation, reduces apoptosis, and supports preservation of functional beta cell mass in metabolic stress conditions.
Pathway / Mechanistic Context
GLP-1 Receptor Activation Semaglutide binds and activates glucagon-like peptide-1 (GLP-1) receptors on pancreatic beta cells, intestinal L-cells, and brain neurons, triggering cAMP-dependent signaling cascades. Insulin Secretion Enhancement GLP-1 receptor activation on beta cells promotes insulin synthesis and glucose-dependent secretion, enhancing insulin availability and glucose uptake in peripheral tissues. Glucagon Suppression Semaglutide suppresses glucagon release from alpha cells in response to GLP-1 receptor signaling, reducing hepatic glucose production and supporting glycemic control. Gastric Motility Slowing The peptide slows gastric emptying through GLP-1 receptor activation on vagal afferent neurons, reducing meal-stimulated glucose excursions and promoting satiety. Central Appetite Suppression Semaglutide crosses blood-brain barrier and activates GLP-1 receptors in hypothalamic appetite centers, reducing hunger signals and enhancing satiety. Beta Cell Preservation GLP-1 signaling promotes beta cell proliferation, reduces apoptosis, and supports preservation of functional beta cell mass in metabolic stress conditions.
Preclinical Research Summary
Semaglutide is supplied as sterile aqueous solution or lyophilized powder at concentrations of 1–10 mg/mL. Storage at 2–8°C; shelf-life 12–24 months for solutions, 24–36 months for lyophilized material. Analytical testing includes HPLC purity verification (≥95%), HPLC-MS molecular confirmation, amino acid analysis, fatty acid acylation verification, and microbial sterility/endotoxin testing. Certificate of Analysis provided with each lot.
Preclinical Research Summary
Semaglutide is supplied as sterile aqueous solution or lyophilized powder at concentrations of 1–10 mg/mL. Storage at 2–8°C; shelf-life 12–24 months for solutions, 24–36 months for lyophilized material. Analytical testing includes HPLC purity verification (≥95%), HPLC-MS molecular confirmation, amino acid analysis, fatty acid acylation verification, and microbial sterility/endotoxin testing. Certificate of Analysis provided with each lot.
RUO Disclaimer
RESEARCH USE ONLY (RUO) This product is intended exclusively for laboratory research and is not approved for clinical use or human/animal administration. Not manufactured for pharmaceutical use. Users assume responsibility for suitability determination, proper storage, safety compliance, and regulatory adherence. Institutional approval (IACUC, IRB) may be required. Information provided is for research reference only and does not constitute medical advice or therapeutic claims.
RUO Disclaimer
RESEARCH USE ONLY (RUO) This product is intended exclusively for laboratory research and is not approved for clinical use or human/animal administration. Not manufactured for pharmaceutical use. Users assume responsibility for suitability determination, proper storage, safety compliance, and regulatory adherence. Institutional approval (IACUC, IRB) may be required. Information provided is for research reference only and does not constitute medical advice or therapeutic claims.
We are committed to supporting all research customers with consistent standards and professional care.
Subscribe
Subscribe to stay updated at every moment about all our news and product drops.
Terms of Service
Refund Policy
Privacy Policy
Promotional Terms
© Standard BioLabs. All rights reserved.
All products on this site are designated for Research Use Only and are supplied solely for laboratory, analytical, or scientific research purposes by qualified professionals. Products are not intended for human or animal use, and no diagnostic, therapeutic, or clinical use is intended or implied.
Standard BioLabs is a chemical supplier. Standard BioLabs is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Standard BioLabs is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
We are committed to supporting all research customers with consistent standards and professional care.
Subscribe
Subscribe to stay updated at every moment about all our news and product drops.
Terms of Service
Refund Policy
Privacy Policy
Promotional Terms
All products on this site are designated for Research Use Only and are supplied solely for laboratory, analytical, or scientific research purposes by qualified professionals. Products are not intended for human or animal use, and no diagnostic, therapeutic, or clinical use is intended or implied.
Standard BioLabs is a chemical supplier. Standard BioLabs is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Standard BioLabs is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
© Standard BioLabs. All rights reserved.
We are committed to supporting all research customers with consistent standards and professional care.
Subscribe
Subscribe to stay updated at every moment about all our news and product drops.
Terms of Service
Refund Policy
Privacy Policy
Promotional Terms
© Standard BioLabs. All rights reserved.
All products on this site are designated for Research Use Only and are supplied solely for laboratory, analytical, or scientific research purposes by qualified professionals. Products are not intended for human or animal use, and no diagnostic, therapeutic, or clinical use is intended or implied.
Standard BioLabs is a chemical supplier. Standard BioLabs is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Standard BioLabs is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.